SEC Form 1-Z filed by Bio-Path Holdings Inc.
$BPTH
Biotechnology: Pharmaceutical Preparations
Health Care
| Form 1-Z Issuer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-Z EXIT REPORT UNDER REGULATION A | OMB APPROVAL |
| OMB Number: 3235-0723 Estimated average burden hours per response: 1.5 |
1-Z: Filer Information
| Issuer CIK | 0001133818 |
| Issuer CCC | XXXXXXXX |
| File Number | |
| Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? | 
Yes
No
|
| Successor File Number |
| Is this a LIVE or TEST Filing? |
LIVE
TEST
|
| Is this an electronic copy of an official filing submitted in paper format? |  |
| Would you like a Return Copy? | |
Submission Contact Information
| Name | |
| Phone | |
| E-Mail Address |
| Notify via Filing Website only? | |
1-Z: PRELIMINARY INFORMATION
| Exact name of issuer as specified in the issuer's charter | Bio-Path Holdings, Inc. |
| Address of Principal Executive Offices | |
| Address 1 | 625 Stanwix Street |
| Address 2 | #2407 |
| City | Pittsburgh |
| State/Country |
PENNSYLVANIA
|
| Mailing Zip/ Postal Code | 15222 |
| Phone | 630-708-0750 |
| Commission File Number(s) | 024-12601 |
1-Z: PART I Summary Information Regarding the Offering and Proceeds
Summary Information
| Date of qualification of the offering statement | 05-29-2025 |
| Date of commencement of the offering | 05-30-2025 |
| Amount of securities qualified to be sold in the offering | 35714285 |
| Amount of securities sold in the offering | 0 |
| Price per security: |
$
0.1400 |
| The portion of aggregate sales attributable to securities sold on behalf of the issuer |
$
0.00 |
| The portion of aggregate sales attributable to securities sold on behalf of selling securityholders: |
$
0.00 |
Fees in connection with this offering and names of service providers.
| Underwriters - Name of Service Provider | D. Boral Capital | Underwriters - Fees |
$
0.00 |
| Sales Commissions - Name of Service Provider | n/a | Sales Commissions - Fee |
$
0.00 |
| Finders' Fees - Name of Service Provider | n/a | Finders' Fees - Fees |
$
0.00 |
| Accounting or Audit - Name of Service Provider | Ernst & Young | Accounting or Audit - Fees |
$
0.00 |
| Legal - Name of Service Provider | Winstead PC | Legal - Fees |
$
0.00 |
| Promoters - Name of Service Provider | n/a | Promoters - Fees |
$
0.00 |
| Blue Sky Compliance - Name of Service Provider | n/a | Blue Sky Compliance - Fees |
$
0.00 |
| CRD Number of any broker or dealer listed |
| Net proceeds to the issuer |
$
0.00 |
| Clarification of responses (if necessary): | No securities were sold in the Offering. Amount of securities qualified in the Offering is based on the post qualification Offering Circular supplement filed on June 2, 2025 under 253(g)(3). |
1-Z: PART II Certification of Suspension of Duty to File Reports
Certification
| Title of each class of securities covered by this Form | Common Stock |
| Commission File Number(s) | 024-12601 |
| Approximate number of holders of record as of the certification date | 462 |
1-Z: Signature
Signature
Pursuant to the requirements of Regulation A,
| Cik | 0001133818 |
| (Name of issuer as specified in charter) | BIO-PATH HOLDINGS, INC. |
certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.
| (Name of issuer as specified in charter) | BIO-PATH HOLDINGS, INC. |
Has caused this certification to be signed on its behalf by the undersigned duly authorized person.
| By | Vikram Grover |
| Date | 02-25-2026 |
| Title | CEO |